Taken together, the data confirm that TRAF3IP2-AS1 can mediate NONO-TFE3 tRCC progression through regulating the expression PARP1. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.